Publications by authors named "Gavin Choy"

Claim this Profile
T
The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer.
Fang Fang, Joanne Munck, Jessica Tang, Pietro Taverna, Yinu Wang, Gavin Choy

Clin Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors.
Monica Mita, Michael Gordon, Lee Rosen, Nirmal Kapoor, Gavin Choy

Cancer Chemother Pharmacol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors.
Raoul Tibes, Gil Fine, Gavin Choy, Sanjeev Redkar, Pietro Taverna

Cancer Chemother Pharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers.
Gavin Choy, Rajashree Joshi-Hangal, Aram Oganesian, Gil Fine, Scott Rasmussen

Cancer Chemother Pharmacol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PIM kinase activity significantly augments the efficacy of cytarabine.
Kevin R Kelly, Claudia M Espitia, Pietro Taverna, Gavin Choy, Swaminathan Padmanabhan

Br J Haematol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.
Eugene R Schiff, Ching-Lung Lai, Stefanos Hadziyannis, Peter Neuhaus, Norah Terrault, Gavin S Choy

Hepatology· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis